talotrexin has been researched along with nadp in 2 studies
| Studies (talotrexin) | Trials (talotrexin) | Recent Studies (post-2010) (talotrexin) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
|---|---|---|---|---|---|
| 27 | 0 | 4 | 21,608 | 25 | 3,484 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, JM; Meiering, EM; Pardo, J; Rosowsky, A; Wagner, G; Wright, JE | 1 |
| Blakley, RL; Cody, V; Galitsky, N; Luft, JR; Pangborn, W; Rosowsky, A | 1 |
2 other study(ies) available for talotrexin and nadp
| Article | Year |
|---|---|
NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase.
Topics: Antineoplastic Agents; Binding Sites; Crystallography, X-Ray; Folic Acid Antagonists; Humans; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Methotrexate; NADP; Ornithine; Protein Conformation; Pterins; Tetrahydrofolate Dehydrogenase | 1997 |
Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523.
Topics: Binding, Competitive; Crystallization; Crystallography, X-Ray; Folic Acid Antagonists; Humans; NADP; Ornithine; Protein Binding; Pterins; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 1997 |